Home/Health And Wellness/

Aclaris Therapeutics Oral JAK Inhibitor Success in Alopecia Areata

Jonny Smith Reply 11:04 A+ A-

Yesterday, Aclaris announced that their oral ATI-501 JAK 1/3 inhibitor Phase 2 clinical trials were successful in treating patients with alopecia areata (AA). No serious side effects reported.

Not a huge surprise since JAK inhibitors have been proven to work well on alopecia areata patients in the past. But a relief after Aclaris’ topical ATI-502 JAK inhibitor failed to treat alopecia areata patients sufficiently well recently.

The latest trial photos are pretty amazing. One of the best ones:

Aclaris JAK Inhibitor Alopecia Areata Before and After Photo

The post Aclaris Therapeutics Oral JAK Inhibitor Success in Alopecia Areata appeared first on Hair Loss Cure 2020.

Health And Wellness, Health Blogs, Health Care, Health Drinks, Health Drinks for Kids, Health is Wealth, Health Tips

Post a Comment

:noprob:

:smile:

:shy:

:trope:

:sneered:

:happy:

:escort:

:rapt:

:love:

:heart:

:angry:

:hate:

:sad:

:sigh:

:disappointed:

:cry:

:fear:

:surprise:

:unbelieve:

:shit:

:like:

:dislike:

:clap:

:cuff:

:fist:

:ok:

:file:

:link:

:place:

:contact:

Copyright (c) 2018 Healthell - Daily Viral Health News.